CONNIE PIERCE: Open Payments
NPI 1164745261 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 28 payments from 10 companies in 2025. Trend: 2023 $741 · 2024 $652 · 2025 $771
Food & beverage: $672Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $253 |
| Regeneron Healthcare Solutions, Inc. | 8 | $187 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| CSL Behring | 1 | $24 |
| BioCryst US Sales Co., LLC | 1 | $22 |
| Amgen Inc. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
Products named: DUPIXENT, TEZSPIRE, Rhapsido, Hizentra, ORLADEYO, NEMLUVIO, NEFFY.
Industry payments across TN — which companies pay providers there.
